Daniela Kaspar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniela Kaspar has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Anita Ignatius
Institute of Orthopedic Research and Biomechanics, Ulm University Medical Center, Germany
5 shared publications L. Claes
3 shared publicationsA. Ignatius
2 shared publicationsC Neidlinger-Wilke
2 shared publicationsL Claes
2 shared publicationsLutz Claes
Institut für Unfallchirurgische Forschung und Biomechanik, Universität Ulm, Helmholtzstr. 14, 89081 Ulm, Germany
2 shared publications
Latest Publications
- 1 August 2006
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 56 (08) , 605-611
Untersuchung der Toxizität von Polyvinyl-Pyrrolidon-Jod an fibroblastären Zellen (BALB-3T3) und primären humanen Knorpelzellen
Polyvinyl-Pyrrolidon-Jod (Polyvinyl-Pyrrolidon-Jod-Komplex, PVP-Jod, CAS 25655-41-8) ist wegen seines breiten anti-mikrobiellen Wirkungsspektrums und des vergleichsweise geringen Allergierisikos ein weitverbreitetes Antiseptikum, das bereits klinisch zur Spülung offener Gelenke eingesetzt wird, um Entzündungen vorzubeugen. Ergebnisse aus tierexperimentellen Studien und Untersuchungen an Organkulturen liefern widersprüchliche Ergebnisse über die knorpelschädigende Wirkung von PVP-Jod. In-vitro-Untersuchungen über den Einfluss von PVP-Jod auf Knorpelzellkulturen liegen derzeit nicht vor. Ziel dieser Studie war es deshalb, die Wirkung von PVP-Jod auf das Zellwachstum und die Stoffwechselaktivität humaner Knorpelzellen in verschiedenen Konzentrationen und bei unterschiedlichen Expositionszeiten zu untersuchen. Zunächst wurden an fibroblastären Zellen (BALB3T3) mittels Vitalitätstest (MTT-Test) und Proliferationstest (BrdU-ELISA) geeignete Konzentrationen und Einwirkungszeiträume identifiziert, mit denen der Einfluss von PVP-Jod auf die Proteoglykan- und DNA-Synthese von primären humanen Knorpelzellen untersucht wurde. Konzentrationen bis 1 % PVP-Jod hatten keinen Einfluss auf die Proteoglykan- und DNA-Synthese von Knorpelzellen nach Inkubation über 30 min. Eine Einwirkungsdauer von 24 h hatte ab 0,2 % PVP-Jod einen deutlich hemmenden Effekt auf die DNA- und Proteoglykansynthese. Die DNA-Syntheserate war allerdings schon nach 10-minütiger Inkubation mit 0,2 % PVP-Jod beeinträchtigt und mit 1 % PVP-Jod vollständig gehemmt. BALB3T3 reagierten empfindlicher als Knorpelzellen. Die Vitalität und Proliferationsrate war nach gleicher Einwirkungsdauer schon bei 0,5 % PVP-Jod völlig gehemmt. Allerdings erholten sich die Zellen bereits 24 h nach 30-minütiger Inkubation mit 0,5 bzw. 1 % PVP-Jod wieder. Nach Einwirkung von 5 % PVP-Jod erholten sich die Zellen nicht mehr. Zusammenfassend sprechen die Ergebnisse für eine kurze Anwendung (30 min) von PVP-Jod in geringen Konzentrationen (< 1 %) und ergänzen damit Ergebnisse aus Studien über die antimikro-bielle Wirksamkeit geringer PVP-Jod-Konzentrationen und deren Wirksamkeit bei der Behandlung des durch Mikroorganismen geschädigten Gewebes. Study of the Toxicity of Povidone-Iodine for Fibroblast-like Cells (BALB-3T3) and Primary Human Chondrocytes Povidone-iodine (polyvinyl-pyrrolidone-iodine complex, PVP-iodine, CAS 25655-41-8) is a commonly used antiseptic because of its broad spectrum of antimicrobial effect and its comparatively low allergic risk. It is also used for open joint lavage. Animal and organ culture studies provide controversial results about the risk of cartilage damage due to povidone-iodine. There is a paucity of in vitro study data concerning the effect of povidone-iodine on chondrocyte cultures are still missing. The aim of this study was therefore to investigate the effect of different concentrations and exposition times of povidone-iodine on cell growth and differentiation of human chondrocytes. Using of a vitality test (MTT) and a proliferation assay (BrdU) in the fibro-blast-like cell line BALB3T3, suitable concentrations and incubation times were identified to investigate the influence of povidone-iodine on proteoglycan synthesis and DNA synthesis of primary human chondrocytes. Concentrations of up to 1 % povidone-iodine had no significant effect on proteoglycan and DNA synthesis of chondrocytes after incubation for 30 min. An incubation time of 24 h did not inhibit DNA- and proteoglycan synthesis, until a concentration of 0.2 % povidone-iodine was used. DNA synthesis rate was impaired after 10 min incubation with 0.2 % and fully inhibited with 1 % povidone iodine. BALB3T3 reacted more sensitively than chondrocytes. Vitality and proliferation rate were fully inhibited at a concentration of 0.5 % after the same exposition time. However, cells recovered 24 h after 30 min incubation with 0.5 % povidone-iodine. After incubation with 5 % povidone iodine cells did not recover. From the results it can be concluded that low concentrations of povidone-iodine (< 1 %) and short incubation times (< 30 min) have no damaging influence on chondrocytes. Previous studies have reported the antimicrobial effectiveness of low concentrations of povidone-iodine on the reduction of tissue damage by microorganisms. Data from previus studies and the current findings from this investigation support the clinical use of povidone-iodine at low concentrations and short incubation times for antiseptic treatment of cartilage tissues.
- 1 August 2006
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 56 (08) , 605-611
Untersuchung der Toxizität von Polyvinyl-Pyrrolidon-Jod an fibroblastären Zellen (BALB-3T3) und primären humanen Knorpelzellen
Polyvinyl-Pyrrolidon-Jod (Polyvinyl-Pyrrolidon-Jod-Komplex, PVP-Jod, CAS 25655-41-8) ist wegen seines breiten anti-mikrobiellen Wirkungsspektrums und des vergleichsweise geringen Allergierisikos ein weitverbreitetes Antiseptikum, das bereits klinisch zur Spülung offener Gelenke eingesetzt wird, um Entzündungen vorzubeugen. Ergebnisse aus tierexperimentellen Studien und Untersuchungen an Organkulturen liefern widersprüchliche Ergebnisse über die knorpelschädigende Wirkung von PVP-Jod. In-vitro-Untersuchungen über den Einfluss von PVP-Jod auf Knorpelzellkulturen liegen derzeit nicht vor. Ziel dieser Studie war es deshalb, die Wirkung von PVP-Jod auf das Zellwachstum und die Stoffwechselaktivität humaner Knorpelzellen in verschiedenen Konzentrationen und bei unterschiedlichen Expositionszeiten zu untersuchen. Zunächst wurden an fibroblastären Zellen (BALB3T3) mittels Vitalitätstest (MTT-Test) und Proliferationstest (BrdU-ELISA) geeignete Konzentrationen und Einwirkungszeiträume identifiziert, mit denen der Einfluss von PVP-Jod auf die Proteoglykan- und DNA-Synthese von primären humanen Knorpelzellen untersucht wurde. Konzentrationen bis 1 % PVP-Jod hatten keinen Einfluss auf die Proteoglykan- und DNA-Synthese von Knorpelzellen nach Inkubation über 30 min. Eine Einwirkungsdauer von 24 h hatte ab 0,2 % PVP-Jod einen deutlich hemmenden Effekt auf die DNA- und Proteoglykansynthese. Die DNA-Syntheserate war allerdings schon nach 10-minütiger Inkubation mit 0,2 % PVP-Jod beeinträchtigt und mit 1 % PVP-Jod vollständig gehemmt. BALB3T3 reagierten empfindlicher als Knorpelzellen. Die Vitalität und Proliferationsrate war nach gleicher Einwirkungsdauer schon bei 0,5 % PVP-Jod völlig gehemmt. Allerdings erholten sich die Zellen bereits 24 h nach 30-minütiger Inkubation mit 0,5 bzw. 1 % PVP-Jod wieder. Nach Einwirkung von 5 % PVP-Jod erholten sich die Zellen nicht mehr. Zusammenfassend sprechen die Ergebnisse für eine kurze Anwendung (30 min) von PVP-Jod in geringen Konzentrationen (< 1 %) und ergänzen damit Ergebnisse aus Studien über die antimikro-bielle Wirksamkeit geringer PVP-Jod-Konzentrationen und deren Wirksamkeit bei der Behandlung des durch Mikroorganismen geschädigten Gewebes. Study of the Toxicity of Povidone-Iodine for Fibroblast-like Cells (BALB-3T3) and Primary Human Chondrocytes Povidone-iodine (polyvinyl-pyrrolidone-iodine complex, PVP-iodine, CAS 25655-41-8) is a commonly used antiseptic because of its broad spectrum of antimicrobial effect and its comparatively low allergic risk. It is also used for open joint lavage. Animal and organ culture studies provide controversial results about the risk of cartilage damage due to povidone-iodine. There is a paucity of in vitro study data concerning the effect of povidone-iodine on chondrocyte cultures are still missing. The aim of this study was therefore to investigate the effect of different concentrations and exposition times of povidone-iodine on cell growth and differentiation of human chondrocytes. Using of a vitality test (MTT) and a proliferation assay (BrdU) in the fibro-blast-like cell line BALB3T3, suitable concentrations and incubation times were identified to investigate the influence of povidone-iodine on proteoglycan synthesis and DNA synthesis of primary human chondrocytes. Concentrations of up to 1 % povidone-iodine had no significant effect on proteoglycan and DNA synthesis of chondrocytes after incubation for 30 min. An incubation time of 24 h did not inhibit DNA- and proteoglycan synthesis, until a concentration of 0.2 % povidone-iodine was used. DNA synthesis rate was impaired after 10 min incubation with 0.2 % and fully inhibited with 1 % povidone iodine. BALB3T3 reacted more sensitively than chondrocytes. Vitality and proliferation rate were fully inhibited at a concentration of 0.5 % after the same exposition time. However, cells recovered 24 h after 30 min incubation with 0.5 % povidone-iodine. After incubation with 5 % povidone iodine cells did not recover. From the results it can be concluded that low concentrations of povidone-iodine (< 1 %) and short incubation times (< 30 min) have no damaging influence on chondrocytes. Previous studies have reported the antimicrobial effectiveness of low concentrations of povidone-iodine on the reduction of tissue damage by microorganisms. Data from previus studies and the current findings from this investigation support the clinical use of povidone-iodine at low concentrations and short incubation times for antiseptic treatment of cartilage tissues.
- 1 January 2005
- Published by Springer Nature in Der Unfallchirurg
- Vol. 108 (1) , 18-24
Diclofenac hemmt die Proliferation und Matrixbildung osteoblast rer Zellen
Zellkulturstudien wiesen nach, dass nichtsteroidale Antirheumatika osteogene Aktivitäten von Osteoblastenkulturen beeinflussen. Längerfristige Effekte auf die sich differenzierenden Osteoblasten wurden dabei allerdings nicht berücksichtigt. Deshalb wurde der Einfluss von Voltaren® mit dem nichtsteroidalen Wirkstoff Diclofenac auf die Proliferation und Genexpression von SaOS-2-Zellen 2, 9 und 16 Tage nach Inkubation untersucht. 50 μg/ml Diclofenac hatten 2 Tage nach 24-stündiger Inkubation einen hemmenden Effekt auf die Proliferation und Kollagenexpression. Nach 9 und 16 Tagen Kulturdauer waren keine Effekte mehr nachweisbar. Im Gegensatz dazu wurde die Expression der alkalischen Phosphatase erst 9 und 16 Tage nach Inkubation vermindert. Geringere Konzentrationen (1,56 und 0,19 μg/ml) hatten keine Effekte auf die beiden untersuchten Parameter. Im BrdU- und MTT-Test führten 50 μg/ml Diclophenac zu einer Erniedrigung der Stoffwechsel- und Proliferationsrate. Geringere Konzentrationen (≤25 μg/ml) hatten einen geringeren oder keinen Einfluss. Eine medikamentöse Beeinträchtigung verschiedener Knochenzellaktivitäten ist abhängig von der Zelldifferenzierung und nicht auf den Zeitpunkt während oder unmittelbar nach Medikamentengabe beschränkt. In-vitro-Tests von Medikamenten in der Osteoblastenkultur sollten deshalb über einen längeren Zeitraum erfolgen. Cell culture studies have shown that NSAID may influence osteogenic activities of osteoblast cultures. However, these studies did not consider long-term effects on differentiating cells. The influence of Voltaren® with the nonsteroidal agent diclofenac on proliferation and gene expression of the osteoblast-like cell line SaOS-2 was investigated 2, 9, and 16 days after incubation. Two days after 24 h of incubation, 50 μg/ml diclofenac reduced the proliferation and collagen type I expression while 9 and 16 days later no effect was found on either of the parameters. In contrast, 50 μg/ml NSAID had no effect on alkaline phosphatase expression 2 days after incubation while 9 and 16 days later expression had been reduced. Lower concentrations (1.56 and 0.19 μg/ml) had no effects on the studied parameters. BrdU and MTT test showed that 50 μg/ml diclofenac reduced proliferative and metabolic activity. Lower concentrations (≤25 μg/ml) had a lower or no influence. The findings indicate that the NSAID impairment depends on cellular differentiation stage and is not confined to the time during or immediately after NSAID incubation. According to these results in vitro testing of drugs should be performed over a longer time period to detect possible long-term impacts.
- 1 January 2005
- Published by Springer Nature in Der Unfallchirurg
- Vol. 108 (1) , 18-24
Diclofenac hemmt die Proliferation und Matrixbildung osteoblast rer Zellen
Zellkulturstudien wiesen nach, dass nichtsteroidale Antirheumatika osteogene Aktivitäten von Osteoblastenkulturen beeinflussen. Längerfristige Effekte auf die sich differenzierenden Osteoblasten wurden dabei allerdings nicht berücksichtigt. Deshalb wurde der Einfluss von Voltaren® mit dem nichtsteroidalen Wirkstoff Diclofenac auf die Proliferation und Genexpression von SaOS-2-Zellen 2, 9 und 16 Tage nach Inkubation untersucht. 50 μg/ml Diclofenac hatten 2 Tage nach 24-stündiger Inkubation einen hemmenden Effekt auf die Proliferation und Kollagenexpression. Nach 9 und 16 Tagen Kulturdauer waren keine Effekte mehr nachweisbar. Im Gegensatz dazu wurde die Expression der alkalischen Phosphatase erst 9 und 16 Tage nach Inkubation vermindert. Geringere Konzentrationen (1,56 und 0,19 μg/ml) hatten keine Effekte auf die beiden untersuchten Parameter. Im BrdU- und MTT-Test führten 50 μg/ml Diclophenac zu einer Erniedrigung der Stoffwechsel- und Proliferationsrate. Geringere Konzentrationen (≤25 μg/ml) hatten einen geringeren oder keinen Einfluss. Eine medikamentöse Beeinträchtigung verschiedener Knochenzellaktivitäten ist abhängig von der Zelldifferenzierung und nicht auf den Zeitpunkt während oder unmittelbar nach Medikamentengabe beschränkt. In-vitro-Tests von Medikamenten in der Osteoblastenkultur sollten deshalb über einen längeren Zeitraum erfolgen. Cell culture studies have shown that NSAID may influence osteogenic activities of osteoblast cultures. However, these studies did not consider long-term effects on differentiating cells. The influence of Voltaren® with the nonsteroidal agent diclofenac on proliferation and gene expression of the osteoblast-like cell line SaOS-2 was investigated 2, 9, and 16 days after incubation. Two days after 24 h of incubation, 50 μg/ml diclofenac reduced the proliferation and collagen type I expression while 9 and 16 days later no effect was found on either of the parameters. In contrast, 50 μg/ml NSAID had no effect on alkaline phosphatase expression 2 days after incubation while 9 and 16 days later expression had been reduced. Lower concentrations (1.56 and 0.19 μg/ml) had no effects on the studied parameters. BrdU and MTT test showed that 50 μg/ml diclofenac reduced proliferative and metabolic activity. Lower concentrations (≤25 μg/ml) had a lower or no influence. The findings indicate that the NSAID impairment depends on cellular differentiation stage and is not confined to the time during or immediately after NSAID incubation. According to these results in vitro testing of drugs should be performed over a longer time period to detect possible long-term impacts.
- 1 March 2003
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 21 (2) , 320-325
Mitogens are increased in the systemic circulation during bone callus healing
The influence of mechanical tissue strain caused by flexible fracture fixation on the systemic occurrence of systemic mitogens during callus healing was investigated. For this purpose the mitogenic capacity and growth factor concentration of sera from patients undergoing fracture treatment were determined. Sera from 9 patients whose fractures had been stabilized by external fixation were collected before and during fracture treatment. The sera were added to cell culture media of the osteoblastic cell line SaOS‐2. After 5‐6 days cell proliferation was measured. Transforming growth factor‐β1 (TGF‐β1) and insulin‐like growth factor‐I (IGF‐I) concentrations were analyzed in serum samples from different healing stages. Statistics: paired Wilcoxon‐test. Sera from fracture patients decreased SaOS‐2 proliferation in the first week after surgery (ppp<0.05). The higher mitogenic activity of sera suggests an increased level of circulating mitogens. In a previous study this increase had also been observed in patients during distraction osteogenesis treatment but not in patients with primary bone healing by a stable fixated plate. It is therefore assumed that their release from the fracture site is a consequence of mechanical stimulation by interfragmentary movement of fracture ends.© 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
- 1 March 2003
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 21 (2) , 320-325
Mitogens are increased in the systemic circulation during bone callus healing
The influence of mechanical tissue strain caused by flexible fracture fixation on the systemic occurrence of systemic mitogens during callus healing was investigated. For this purpose the mitogenic capacity and growth factor concentration of sera from patients undergoing fracture treatment were determined. Sera from 9 patients whose fractures had been stabilized by external fixation were collected before and during fracture treatment. The sera were added to cell culture media of the osteoblastic cell line SaOS‐2. After 5‐6 days cell proliferation was measured. Transforming growth factor‐β1 (TGF‐β1) and insulin‐like growth factor‐I (IGF‐I) concentrations were analyzed in serum samples from different healing stages. Statistics: paired Wilcoxon‐test. Sera from fracture patients decreased SaOS‐2 proliferation in the first week after surgery (ppp<0.05). The higher mitogenic activity of sera suggests an increased level of circulating mitogens. In a previous study this increase had also been observed in patients during distraction osteogenesis treatment but not in patients with primary bone healing by a stable fixated plate. It is therefore assumed that their release from the fracture site is a consequence of mechanical stimulation by interfragmentary movement of fracture ends.© 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
- 1 July 2002
- Published by Elsevier in Journal of Biomechanics
- Vol. 35 (7) , 873-880
Proliferation of human-derived osteoblast-like cells depends on the cycle number and frequency of uniaxial strain
- 1 July 2002
- Published by Elsevier in Journal of Biomechanics
- Vol. 35 (7) , 873-880
Proliferation of human-derived osteoblast-like cells depends on the cycle number and frequency of uniaxial strain
- 1 December 2000
- Vol. 1 (2) , 161-4
In vitro effects of dynamic strain on the proliferative and metabolic activity of human osteoblasts.
It has been well shown by human and animal studies that mechanical load is an important regulator of skeletal mass and architecture. However, cellular reactions which adapt bone tissue to the mechanical environment are not definitively determined. For this purpose we studied the cell activity of human bone derived cell cultures after mechanical stimulation by cyclic, uniaxial strain at a magnitude occurring in normal loaded bone tissue. Human osteoblasts were isolated from cancellous bone biopsies of 5 different donors. Cell seeding was made in DMEM in a density of 10.000 cells/cm(2) on deformable culture dishes for three days prior to initiating cell stretching at 1000 microstrain, 1Hz for 1800 cycles for two subsequent days with an especially developed cell stretching device. 48h after the second stimulation cells were harvested and cell number was determined with a Coulter Counter. Cell bound alkaline phosphatase activity was analyzed in cell lysates by a colorimetric assay, osteocalcin and CICP (procollagen I propeptide) production were analyzed in cell supernatants with ELISAs. Three parallel cultures were tested. Wilcoxon. In all experiments mechanical stimulation resulted in a significant increase in cell number (10-48%) and CICP release (7-49%). Simultaneously a significant decrease in alkaline phosphatase activity (9-25%) and osteocalcin release (5-32%) could be observed. The results demonstrate that cyclic strain at physiologic magnitude leads to an increase of early osteoblast activities related to matrix production while those activities which are characteristic for the differentiated osteoblast and relevant for matrix mineralization are decreased. These new findings confirm in vivo observations about the importance of dynamic strain for bone formation during fracture healing and bone remodeling and could contribute to the optimization of fracture healing.
- 1 December 2000
- Vol. 1 (2) , 161-4
In vitro effects of dynamic strain on the proliferative and metabolic activity of human osteoblasts.
It has been well shown by human and animal studies that mechanical load is an important regulator of skeletal mass and architecture. However, cellular reactions which adapt bone tissue to the mechanical environment are not definitively determined. For this purpose we studied the cell activity of human bone derived cell cultures after mechanical stimulation by cyclic, uniaxial strain at a magnitude occurring in normal loaded bone tissue. Human osteoblasts were isolated from cancellous bone biopsies of 5 different donors. Cell seeding was made in DMEM in a density of 10.000 cells/cm(2) on deformable culture dishes for three days prior to initiating cell stretching at 1000 microstrain, 1Hz for 1800 cycles for two subsequent days with an especially developed cell stretching device. 48h after the second stimulation cells were harvested and cell number was determined with a Coulter Counter. Cell bound alkaline phosphatase activity was analyzed in cell lysates by a colorimetric assay, osteocalcin and CICP (procollagen I propeptide) production were analyzed in cell supernatants with ELISAs. Three parallel cultures were tested. Wilcoxon. In all experiments mechanical stimulation resulted in a significant increase in cell number (10-48%) and CICP release (7-49%). Simultaneously a significant decrease in alkaline phosphatase activity (9-25%) and osteocalcin release (5-32%) could be observed. The results demonstrate that cyclic strain at physiologic magnitude leads to an increase of early osteoblast activities related to matrix production while those activities which are characteristic for the differentiated osteoblast and relevant for matrix mineralization are decreased. These new findings confirm in vivo observations about the importance of dynamic strain for bone formation during fracture healing and bone remodeling and could contribute to the optimization of fracture healing.
- 1 January 2000
- Published by Elsevier in Journal of Biomechanics
- Vol. 33 (1) , 45-51
Dynamic cell stretching increases human osteoblast proliferation and CICP synthesis but decreases osteocalcin synthesis and alkaline phosphatase activity
- 1 January 2000
- Published by Elsevier in Journal of Biomechanics
- Vol. 33 (1) , 45-51
Dynamic cell stretching increases human osteoblast proliferation and CICP synthesis but decreases osteocalcin synthesis and alkaline phosphatase activity
- 1 January 2000
- Published by Springer Nature
- p. 201-214
Experimentelle Unfallchirurgie IV Knorpel - Tissue Engineering
- 1 January 2000
- Published by Springer Nature
- p. 201-214
Experimentelle Unfallchirurgie IV Knorpel - Tissue Engineering
- 1 January 2000
- Published by Springer Nature
- p. 144-158
Experimentelle Unfallchirurgie III Preisträgersitzung
- 1 January 2000
- Published by Springer Nature
- p. 144-158
Experimentelle Unfallchirurgie III Preisträgersitzung
- 1 January 1997
- Published by Springer Nature
- p. 877
Einfluß der Dehnungsamplitude bei zyklischer Dehnung auf die Proliferation einer humanen osteoblastischen Zellinie
- 1 January 1997
- Published by Springer Nature
- p. 877
Einfluß der Dehnungsamplitude bei zyklischer Dehnung auf die Proliferation einer humanen osteoblastischen Zellinie